修改肝动脉输液化疗与伦瓦提尼布和卡梅利祖马布结合治疗高级HCC:两个病例报告
Yuan Tian1, Wenbiao Jin1, Honghua Sun1
1Department of Oncology, The Affiliated Hospital of Yanbian University, Yanji City, Jilin Province, People's Republic of China.
Journal of hepatocellular carcinoma
|October 4, 2023
概括
修改肝动脉输液化疗 (mHAIC) 与伦瓦替尼和卡梅利祖马布结合,为具有大型瘤或门静脉瘤血栓 (PVTT) 的晚期肝细胞癌 (HCC) 提供安全有效的治疗方法,改善了患者的服药性.
科学领域:
- 肝胆道恶性瘤 肝胆道恶性瘤
- 干预性瘤学干预性瘤学
- 系统性癌症治疗系统性癌症治疗
背景情况:
- 晚期肝细胞癌 (HCC),特别是大型瘤或带有门静脉瘤血栓 (PVTT) 的瘤,具有严重的治疗挑战,预后不佳.
- 肝动脉输液化疗 (HAIC) 是有前途的,但受到漫长的手术和患者不合格的限制.
- 修改HAIC (mHAIC) 提供了一种潜在的解决方案,以减轻并发症并增强患者的坚持.
更多相关视频
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.4K
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
